Hexamollamide, a hexapeptide from an Okinawan ascidian Didemnum molle

Toshiaki Teruya; Hiroaki Sasaki; Kiyotake Suenaga

doi:10.1016/j.tetlet.2008.06.086

Hexamollamide, a hexapeptide from an Okinawan ascidian Didemnum molle

Toshiaki Teruya, Hiroaki Sasaki, Kiyotake Suenaga

Department of Chemistry

Research output: Contribution to journal › Article

15 Citations (Scopus)

Abstract

The bioassay-guided fractionation of the cytotoxic constituents of the Okinawan ascidian Didemnum molle led to the isolation of hexamollamide (1), a hexapeptide. The gross structure and relative stereostructure of 1 were established by spectroscopic analysis including 2D NMR techniques and single-crystal X-ray diffraction analysis. The absolute stereostructure was determined by chiral HPLC analysis of acid hydrolysates of 1. Hexamollamide (1) exhibits moderate cytotoxicity against HeLa S₃ cells.

Original language	English
Pages (from-to)	5297-5299
Number of pages	3
Journal	Tetrahedron Letters
Volume	49
Issue number	36
DOIs	https://doi.org/10.1016/j.tetlet.2008.06.086
Publication status	Published - 2008 Sep 1

Fingerprint

ASJC Scopus subject areas

Biochemistry
Drug Discovery
Organic Chemistry

Cite this

Teruya, T., Sasaki, H., & Suenaga, K. (2008). Hexamollamide, a hexapeptide from an Okinawan ascidian Didemnum molle. Tetrahedron Letters, 49(36), 5297-5299. https://doi.org/10.1016/j.tetlet.2008.06.086

@article{e030f7439b4a4080bf3be28e4db295dd,

title = "Hexamollamide, a hexapeptide from an Okinawan ascidian Didemnum molle",

abstract = "The bioassay-guided fractionation of the cytotoxic constituents of the Okinawan ascidian Didemnum molle led to the isolation of hexamollamide (1), a hexapeptide. The gross structure and relative stereostructure of 1 were established by spectroscopic analysis including 2D NMR techniques and single-crystal X-ray diffraction analysis. The absolute stereostructure was determined by chiral HPLC analysis of acid hydrolysates of 1. Hexamollamide (1) exhibits moderate cytotoxicity against HeLa S3 cells.",

author = "Toshiaki Teruya and Hiroaki Sasaki and Kiyotake Suenaga",

year = "2008",

month = sep

day = "1",

doi = "10.1016/j.tetlet.2008.06.086",

language = "English",

volume = "49",

pages = "5297--5299",

journal = "Tetrahedron Letters",

issn = "0040-4039",

publisher = "Elsevier Limited",

number = "36",

}

TY - JOUR

T1 - Hexamollamide, a hexapeptide from an Okinawan ascidian Didemnum molle

AU - Teruya, Toshiaki

AU - Sasaki, Hiroaki

AU - Suenaga, Kiyotake

PY - 2008/9/1

Y1 - 2008/9/1

N2 - The bioassay-guided fractionation of the cytotoxic constituents of the Okinawan ascidian Didemnum molle led to the isolation of hexamollamide (1), a hexapeptide. The gross structure and relative stereostructure of 1 were established by spectroscopic analysis including 2D NMR techniques and single-crystal X-ray diffraction analysis. The absolute stereostructure was determined by chiral HPLC analysis of acid hydrolysates of 1. Hexamollamide (1) exhibits moderate cytotoxicity against HeLa S3 cells.

AB - The bioassay-guided fractionation of the cytotoxic constituents of the Okinawan ascidian Didemnum molle led to the isolation of hexamollamide (1), a hexapeptide. The gross structure and relative stereostructure of 1 were established by spectroscopic analysis including 2D NMR techniques and single-crystal X-ray diffraction analysis. The absolute stereostructure was determined by chiral HPLC analysis of acid hydrolysates of 1. Hexamollamide (1) exhibits moderate cytotoxicity against HeLa S3 cells.

UR - http://www.scopus.com/inward/record.url?scp=47549088623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47549088623&partnerID=8YFLogxK

U2 - 10.1016/j.tetlet.2008.06.086

DO - 10.1016/j.tetlet.2008.06.086

M3 - Article

AN - SCOPUS:47549088623

VL - 49

SP - 5297

EP - 5299

JO - Tetrahedron Letters

JF - Tetrahedron Letters

SN - 0040-4039

IS - 36

ER -

Access to Document

10.1016/j.tetlet.2008.06.086